Kentucky Injury Lawyers

Pregnant Women May Not Be Properly Warned About Depakote’s Risks

Published on Jul 5, 2017 at 2:05 pm in Dangerous Drugs.

Depakote ER (divalproex sodium) is a drug produced by AbbVie Inc. designed to treat many conditions such as, seizures, bipolar disorder, and migraine headaches. Depakote has proved to cause several severe complications. Now new lawsuits are suggesting that pregnant women are not being adequately warned about the risks of continuing to take the drug while pregnant.

Depakote has a list of negative side effects including, loss of consciousness, irregular heartbeat, and of most concern, the harm of a fetus during pregnancy. Many lawsuits against this drug indicate that doctors were not properly informed of the side effects the drug could have on their patients. RXList.com states that Depakote is not recommended for pregnant women but that women should continue taking the drug if they are taking it for serious conditions.

Drug Manufacturer Fined for Unfairly Raising Prices

Published on Feb 7, 2017 at 12:00 pm in Dangerous Drugs.

A recent settlement shocked the pharmaceutical world as the drug maker Mallinckrodt has agreed to pay a $100 million fine to settle Federal Trade Commission charges for taking illegal action to maintain its monopoly of a specialty drug for infants.  H.P. Acthar Gel is an adrenocorticotropic hormone drug prescribed to treat infantile spasms, a rare seizure disorder affecting infants.  It is also used as a life-saving last-resort for other serious medical conditions, including multiple sclerosis.

The deal was reached with the Federal Trade Commission and the states of Alaska, Maryland, New York, Texas, and Washington.  Mallinckrodt must pay the fine and allow a competitive drug alternative to be produced.  A spokesperson for the New York Attorney General Eric Schneiderman who was involved in the settlement said that Mallinckrodt’s U.S. subsidiary, formerly known as Questcor Pharmaceuticals Inc., purchased Acthar in 2001 and began to raise the price.  Acthar went from costing $40 a vial to more than $34,000 a vial, an 85,000% increase.  Today, a single dose for treatment costs well above $100,000.

Cipro Might Be Linked to the Injuries of Gulf War Veterans

Published on Nov 9, 2016 at 11:00 am in Dangerous Drugs.

Cipro, generically known as ciprofloxacin, is a popular antibiotic belonging to the same classification (fluoroquinolone) as drugs like Levaquin and Avelox. It’s been on the market for almost 30 years and is commonly used to treat bacterial infections including respiratory tract infections, UTIs, skin infections, and more. It’s also commonly used to treat patients who have been exposed to anthrax. 

5 Facts You May Not Know about IVC Filters

Published on Apr 14, 2016 at 1:49 pm in Dangerous Drugs.

An IVC filter is a small, cage-like device that gets surgically inserted around the inferior vena cava, a major vein which carries blood to the heart and lungs. The device is designed to permanently stop blood clots from traveling to the lungs and is usually only inserted after other anticoagulation treatment courses are unsuccessful. Despite the fact that IVC filters have helped some patients live longer, they have caused other patients to suffer from a myriad of serious complications including deep vein thrombosis (DVT), cardiac tamponade, pulmonary embolism, hemorrhage, and even death.

If you or someone you know has had the device inserted or plans on having the surgery done, we have a wealth of important information you should take a look at, but in addition, we have also come up with a list of 5 interesting facts you may not know about the IVC filter:

  1. The majority of IVC filters are inserted without telling the patient about how to care for the device afterwards.

As odd as it may sound, surgeons will often place an IVC filter inside a patient without telling them that it should later be removed if it’s no longer needed. Patients will often assume that the device should stay in forever only because they were not told differently. Doctors will often say nothing at all regarding the after care of the device, in fact.

  1. The longer an IVC filter remains in the body, the higher the risk of injury.

If the patient is no longer at risk for developing blood clots, it’s best for the IVC filter to be removed 1-2 months after insertion. The FDA even recommends device retrieval in cases where it’s no longer needed. The most dangerous risks associated with IVC filters usually happen in patients who have had the device for many years. Long term risks can include IVC occlusion, lower limb deep vein thrombosis, and even hemorrhage and/or death.

  1. A recent study suggests that IVC filters don’t even provide any significant medical benefit.

The medical field advances quickly. IVC filters were once thought to be incredible life savers, but recent findings in a study conducted by Mark R. Hemmila in the October 2015 issue of Annals of Surgery report that “High rates of prophylactic IVC filter placement have no effect on reducing trauma patient mortality and are associated with an increase in DVT events.”

  1. In 2016, a major, 5-year study began which aims to study the safety and effectiveness of 7 brands of IVC filters.

Most case studies involving IVC filters are performed on filters that are manufactured by companies under heavy legal scrutiny such as those created by C.R. Bard and Cook Medical. In 2016, a new study sponsored by the Society for Vascular Surgery (SVS) and the Society of Interventional Radiology (SIR) went underway which will look at seven major brands of IVC filters and how they affect patients over the course of five years.

The study is called PRESERVE which stands for “Predicting the Safety and Effectiveness of Inferior Vena Cava Filters” and will involve over 2,100 patients and 60 different medical communities.

  1. At least 27 deaths have occurred due to IVC filters.

According to evidence discussed during a major NBC News report in 2015, at least 27 deaths have directly resulted from complications suffered after IVC filter insertion. The FDA has collected over 900 adverse device reports from the years 2005-2010 alone. As of December 2015, there are over 120 pending lawsuits directed at Cook Medical and C.R. Bard regarding patients and their loved ones who have suffered from damage caused by IVC filters.

The numbers and facts don’t lie. IFV filters, once considered safe, are no longer safe and should be either taken off the market completely or altered until they become safer. Furthermore, the manufacturers should not only be creating safer devices but also properly informing physicians and patients regarding the risks and realities concerning the filters and their recommended retrieval.

If you or someone you love has experienced medical complications due to an IVC filter, it’s not too late to get involved in the pending lawsuits and potentially receive compensation. Contact Louisville personal injury lawyer Tad Thomas of Thomas Law Offices to find out how.

Tad Thomas Appointed to the Plaintiff’s Steering Committee in Levaquin Multidistrict Litigation

Published on Mar 25, 2016 at 11:37 am in Dangerous Drugs, Press Release.

LOUISVILLE, KY, March 25, 2016— Tad Thomas of Thomas Law Offices has been appointed to the Plaintiff’s Steering Committee in the federal fluoroquinolone (commonly known as Levaquin) product liability multidistrict litigation (MDL) which was initiated last year. The Plaintiff’s Steering Committee (PSC) is a committee of ten attorneys throughout the United States that will assist the entire plaintiff’s multidistrict litigation group in coordinating proceedings between the plaintiffs and attorneys, preparing the plaintiffs for trial, and serving as a possible litigator during trial.